Advertisement

Topics

Regeneron Company Profile

14:11 EDT 23rd June 2018 | BioPortfolio

Regeneron has several product candidates progressing through all stages of human clinical trials, for the potential treatment of a diverse set of diseases, including cancer, eye diseases, and inflammation.Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammation. The Company also has preclinical programs in asthma, allergies, and other diseases and disorders. Regeneron has developed several proprietary platform technologies, which it has incorporated into a comprehensive discovery and development process designed to understand thoroughly the biology of specific disease states, discover potential therapeutic candidates, and evaluate these candidates in clinical trials.

Location

777 Old Saw Mill River Road
Tarrytown
New York
10591
United States of America

Contact

Phone: (914) 345-7400
Email: jobs@regeneron.com


News Articles [230 Associated News Articles listed on BioPortfolio]

Regeneron and ISA enter trial collaboration; Regeneron gets licensing option

Regeneron Pharmaceuticals Inc. and ISA Pharmaceuticals BV penned an agreement to evaluate an immunotherapy for head and neck and cervical cancers combining Regeneron’s PD-1 antibody cemiplimab (REGN...

Regeneron Talent Search Doles Out $1.8 Million in Awards to High School Scientists

Training the next generation of scientists is a key for the future of the biotech industry and Regeneron Pharmaceuticals is taking a lead in that responsibility through its sponsorship of the Regenero...

Regeneron collaborates with Zoetis to research antibody therapies for animals

Regeneron Pharmaceuticals, Inc. and Zoetis Inc. today announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary tre...

Regeneron 4th-qtr profits and sales beat estimates

US biotech Regeneron Pharmaceuticals today announced financial results for the fourth quarter and full…

Regeneron's coming late to a group of drugs that's already...

Regeneron's coming late to a group of drugs that's already worth billions - here's why the company thinks it can still compete The drug, cemiplimab, is a checkpoint inhibitor, a kind of dr...

Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives

Regeneron Pharmaceuticals and partner Sanofi report new data this morning from a large, highly-anticipated trial suggesting that their drug alirocumab (Praluent) may reduce the risk of death for peop...

STAT Plus: What you need to know about Regeneron’s all-important cholesterol trial

Regeneron Pharmaceuticals (REGN) is about to have a chance to prove that its pricey, seldom-used cardiovascular drug can improve patients’ lives.

Regeneron Keeps Science at the Center

Thirty years ago, neurologist Leonard S. Schliefer, MD, PhD, founded Regeneron, a life sciences company dedicated to discovering, developing and bringing new medications to the patients who need them.

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Eylea [Regeneron Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA (aflibercept) Injection For Intravitreal Injection Ini...

Arcalyst [Regeneron Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST (rilonacept)Injection for Subcutaneous UseIni...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Intravitreal Ziv-Aflibercept for Diabetic Macular Edema: 48-Week Outcomes.

To study the safety and efficacy of intravitreal injections of ziv-aflibercept (IVI-ZA) (Zaltrap; Sanofi-Aventis and Regeneron Pharmaceuticals, Tarrytown, NY) during a period of 48 weeks in patients w...

36-Month Evaluation of Intravitreous Aflibercept Injection for Wet Age-Related Macular Degeneration in Patients Previously Treated With Ranibizumab or Bevacizumab.

In the ASSESS study, patients with neovascular age-related macular degeneration transitioned from other anti-vascular endothelial growth factor therapies to intravitreous aflibercept (Eylea; Regeneron...

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

Background No systemic therapies have been approved for the treatment of advanced cutaneous squamous-cell carcinoma. This cancer may be responsive to immune therapy, because the mutation burden of the...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

This Phase 3, multicenter, randomized, masked, controlled, parallel group study is designed to demonstrate that suprachoroidal (SC) CLS-TA administered with intravitreal (IVT) aflibercept ...

RGX-314 Gene Therapy for Neovascular AMD Trial

Excessive vascular endothelial growth factor (VEGF) plays a key part in promoting neovascularization and edema in neovascular (wet) age-related macular degeneration (nAMD). VEGF inhibitors...

Interleukin-1 Trap to Treat Autoinflammatory Diseases

Autoinflammatory diseases are illnesses characterized by episodes of inflammation that, unlike autoimmune disorders, lack the production of high titer autoantibodies or antigen-specific T ...

Companies [6 Associated Companies listed on BioPortfolio]

Regeneron Pharmaceuticals, Inc.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept...

Regeneron Pharmaceuticals

Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candida...

Regeneron

Regeneron has several product candidates progressing through all stages of human clinical trials, for the potential treatment of a diverse set of diseases, including cancer, eye diseases, and inflamma...

ARTEMIS Pharmaceuticals

ARTEMIS Pharmaceuticals, based in Cologne Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in ve...

Psychiatric Genomics, Inc.

Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar ...

More Information about "Regeneron" on BioPortfolio

We have published hundreds of Regeneron news stories on BioPortfolio along with dozens of Regeneron Clinical Trials and PubMed Articles about Regeneron for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Regeneron Companies in our database. You can also find out about relevant Regeneron Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record